|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
13.000 +0.240 (+1.881%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 1.838% | 3.107% | 3.259% | 3.142% | 3.093% |
| ROAE (%) | 5.558% | 9.650% | 10.755% | 10.334% | 10.117% |
| Return on Capital Employed (%) | 4.205% | 6.424% | 7.113% | 7.364% | 6.538% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | -- | -- | -- | -- | -- |
| EBITDA Margin (%) | 4.145% | 5.178% | 5.063% | 5.057% | 4.704% |
| Pre-tax Profit Margin (%) | 2.710% | 3.797% | 3.773% | 3.739% | 3.357% |
| Net Profit Margin (%) | 1.448% | 2.421% | 2.360% | 2.343% | 2.187% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.327 X | 1.351 X | 1.269 X | 1.220 X | 1.315 X |
| Quick Ratio (X) | 1.028 X | 1.039 X | 0.973 X | 0.947 X | 0.981 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 62.105% | 60.632% | 63.860% | 63.307% | 63.959% |
| Total Debt / Total Assets (%) | 24.489% | 22.511% | 24.941% | 24.619% | 25.261% |
| Net Debt / Total Assets (%) | 10.092% | 8.681% | 11.241% | 9.674% | 12.013% |
| Total Debt / Shareholders' Funds (%) | 75.756% | 66.507% | 82.582% | 80.980% | 83.089% |
| Long Term Debt / Shareholders' Funds (%) | 10.706% | 11.275% | 17.407% | 5.920% | 24.700% |
| Net Debt / Shareholders' Funds (%) | 31.220% | 25.648% | 37.220% | 31.820% | 39.515% |
| Net Cash / (Debt) ($) | (21.393B) | (17.200B) | (18.372B) | (14.432B) | (16.461B) |
| Net Cash / (Debt) per share ($) | (5.777) | (4.652) | (6.464) | (5.078) | (5.792) |
| Total Debt / Capital Employed (%) | 57.936% | 51.006% | 56.921% | 60.158% | 55.455% |
| Interest Coverage Ratio (X) | 4.742 X | 6.214 X | 6.364 X | 6.082 X | 5.457 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | -- | -- | -- | -- | -- |
| Receivables Turnover (Day) | 100.543 Day | 100.655 Day | 95.064 Day | 95.716 Day | 87.545 Day |
| Payables Turnover (Day) | 74.458 Day | 73.605 Day | 67.468 Day | 71.004 Day | 70.146 Day |
| Remarks: | Real time quote last updated: 29/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,941,911 |
| %Change | 12.725% |
| EPS / (LPS) | RMB 0.790 |
| NBV Per Share (¥) | RMB 18.898 |